KYMBERLY CULLAR: Open Payments
NPI 1255363800 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,648 in 73 payments from 14 companies in 2025. Trend: 2023 $1,990 · 2024 $2,565 · 2025 $1,648
Food & beverage: $1,648
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $498 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $360 |
| Corium, LLC | 13 | $219 |
| Janssen Pharmaceuticals, Inc | 5 | $114 |
| E.R. Squibb & Sons, L.L.C. | 3 | $112 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| Collegium Pharmaceutical, Inc. | 1 | $69 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Tris Pharma Inc | 2 | $30 |
| Lundbeck LLC | 1 | $26 |
Products named: REXULTI, CAPLYTA, Azstarys, SPRAVATO, COBENFY, INGREZZA, Jornay PM, Auvelity.
Industry payments across TX — which companies pay providers there.
